Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

AFib ablation outperforms drugs in CABANA trial

Catheter ablation was found to be superior to optimal drug therapy for the primary treatment of atrial fibrillation (AFib) in the randomized CABANA trial presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston. However, there was a caveat.

  • Read more about AFib ablation outperforms drugs in CABANA trial

$43M research initiative targets cognitive decline by merging vascular, brain science

The American Heart Association/American Stroke Association (AHA/ASA), the Paul G. Allen Frontiers Group and other partners are devoting $43 million to fund a research initiative for better ways to prevent and treat age-related cognitive impairment.

  • Read more about $43M research initiative targets cognitive decline by merging vascular, brain science

3-step antibiotic strategy may reduce CIED infections

‘Notably high’ rates of PTSD, depression and anxiety seen in patients with implantable heart devices

Administering antibiotics incrementally in the perioperative stage has the potential to modestly reduce infections related to cardiac implantable electronic devices (CIEDs), according to a study presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston.

  • Read more about 3-step antibiotic strategy may reduce CIED infections

INFINITT Achieves ACC-NCDR Certification for CathPCI® Registry

Phillipsburg, NJ—INFINITT North America, an award-winning developer of image and data management solutions for healthcare, announced today that they have achieved certification from the American College of Cardiology (ACC), demonstrating that INFINITT Cardiology Suite-v. 1.0.8.1 meets NCDR requirements for version 5 of the CathPCI Registry®.

  • Read more about INFINITT Achieves ACC-NCDR Certification for CathPCI® Registry

Previously Invisible Long QT Syndrome Now Observable With Machine Learning

MOUNTAIN VIEW, Calif., May 10, 2018 — AliveCor, the leader in artificial intelligence and FDA-cleared personal electrocardiogram (ECG) technology, today announced an important milestone in its work with Mayo Clinic on Long QT Syndrome (LQTS).

  • Read more about Previously Invisible Long QT Syndrome Now Observable With Machine Learning

6-minute walk test predicts cognitive problems after heart surgery

Each 50-meter increase in a six-minute walk test was associated with 20 percent lower odds of developing cognitive dysfunction after cardiac surgery, according to a single-center study from Japan published in The Annals of Thoracic Surgery.

  • Read more about 6-minute walk test predicts cognitive problems after heart surgery

Folic acid supplements reduce stroke risk by 73% in certain hypertensive patients

Folic acid supplementation may dramatically reduce the risk of first stroke in patients with hypertension, low platelet count and high homocysteine levels, suggests a study published online May 7 in the Journal of the American College of Cardiology.

  • Read more about Folic acid supplements reduce stroke risk by 73% in certain hypertensive patients

PTSD linked to higher AFib risk in young veterans

An analysis of more than one million post-9/11 veterans suggests a new diagnosis of post-traumatic stress disorder (PTSD) is associated with a greater likelihood of developing atrial fibrillation (AF). The study is scheduled to be presented May 11 at the Heart Rhythm Society’s annual scientific sessions in Boston.

  • Read more about PTSD linked to higher AFib risk in young veterans

CMS’s Verma: Upside-only ACOs not working

CMS Administrator Seema Verma, MPH

CMS Administrator Seema Verma, MPH, said accountable care organizations (ACOs) that haven’t taken on downside risk “are not producing results,” suggesting the agency could reevaluate those payment models.

  • Read more about CMS’s Verma: Upside-only ACOs not working

15% of hypertensive women on meds have poor pregnancy outcomes

Despite normal baseline blood pressures without medications before 20 weeks of gestation, pregnant women with chronic hypertension are at an increased risk of poor outcomes compared with women without, according to new research published in the May issue of Obstetrics & Gynecology.

  • Read more about 15% of hypertensive women on meds have poor pregnancy outcomes

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …790
    • Page 791
    • Page 792
    • Page 793
    • Current page 794
    • Page 795
    • Page 796
    • Page 797
    • Page 798 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme